|
|
7325 Aspen Lane
Brooklyn Park, MN 55428 USA
phone:763.488.4700
fax:(952) 947-8770
|
| Symbol |
Private |
| Founded |
1986 |
| Employees |
|
|
|
| www.cimalabs.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Prescription and OTC medication based on proprietary, orally disintegrating technologies. |
|
| Management |
| Sarma Duddu, Ph.D., General Manager CIMA LABS and Vice President Drug Delivery Technologies; Richard Welter, Ph.D., Vice President, Business Development; Ken Manning, Ph.D., Vice President, Quality; Derek Moe, Ph.D., Group Director of Drug Delivery; Nick Valentine, Controller |
|
|
| |
| Keywords |
| transmucosal, granules, solubilization, tamper-deterrent, durasolv |
|
|
|
|
|
| Description |
|
CIMA LABS INC., a subsidiary of Cephalon, Inc., is a drug delivery technology company. They develop and manufacture prescription and over-the-counter medication based on proprietary, orally disintegrating technologies (also referred to as fast dissolve, fast melt and fast disintegrating). |
|
| Products / Services |
OraSolv and DuraSolv
|
|
| Technology / Differentiation |
| OraSolv and DuraSolv orally disintegrating tablets (ODTs) disperse quickly in the mouth without chewing or the need for water - making it easier for patients to take medication. OraVescent is an oral transmucosal tablet that can be administered buccally or sublingually. |
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members